Fascioliasis
📧 Sign up to get email alerts when something new happens for Fascioliasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-02-17FDA Approved: EGATEN — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for EGATEN (triclabendazole) from Novartis Pharmaceuticals Corporation. The action approves a su…
-
FDA approval · 2019-02-13FDA Approved: EGATEN — Original Application (Novartis Pharmaceuticals Corporation)
The FDA approved EGATEN (triclabendazole) under an original NDA from Novartis Pharmaceuticals Corporation. The approval is for the treatment…